médis - cphi online · 2017/18 manufacturing license of the new site and beginning of production....

MédiS GROUP

MédiS GROUP and its

subsidiaries

MédiS GROUP

AN INTERNATIONAL PHARMACEUTICAL

GROUP

Manufactures and markets generic

medicines which comply withINTERNATIONAL STANDARDS

MédiS GROUP

Tunisia

Algeria

Senegal

Czech

Republic

KEY DATES

Creation of MédiS

The beginning of a story …

Creation of the

subsidiary

INPHA-MédiSin Algeria

The first MAA Creation of

MédiS

INTERNATIONAL

in Czech Republic

Launch of the

Biosimilars project

Entry in the

TOP 10

MédiS : leader of

local industries

Creation of

NEAPOLIS

PHARMAOncology and DPI

Creation of MédiS GROUP

manufacturing

license

of DPI Unit

Acquisition

of WPS

► MédiSSENEGAL

Creation of

TUNIVET

Manufacturing and marketing

of Medicines in ALGERIA

THE LARGEST INJECTABLES SITE IN THE MENA

2006Merging and creation :

INPHA-MédiS: Specialized

in liquid forms

2010Extension :

Manufacturing of

dry forms

2013/14Beginning of construction

NEW site of production :

DPI & Injectable forms

2016Ranking TOP 20

laboratories

2017/18Manufacturing license of the new

site and beginning of

production

Manufacturing and marketing of

Medicines in Czech Republic

2007Creation of

MédiS

INTERNATIONAL

2008The start of the project

MédiS INTERNATIONAL

2009Start of the production in primary

and secondary packaging

(Tablets and Capsules )

Manufacturing and marketing of

high-value added medicines

2011Beginning of the project

2015Developpment of

DPI & Oncology products

2016Manufacturing License of

the DPI site

2017Manufacturing license of the

oncology site

2018Beginning of production and

marketing

Satisfy the local and

regional needs in

chemotherapy

and Biosimilar

medicines

100% Tunisian

Investment

> 50 M DT

Respect of Best

Manufacturing

Practices and

Security standards

Manufacturing and marketing of

high-value added medicines

Manufacturing and marketing

of medicines for West Africa

1973Creation of SIPOA

(Société Industrielle

et Pharmaceutique

de l’Ouest Africain)

1997Rhône Poulenc(Entry and majority

shareholder)

2006AfricasoinsProduction

2000Aventis Pharma

2008Winthrop Pharma

Sénégal

13 Avril

2017MédiS

Sénégal

Winthrop Pharma Senegal (Ex SANOFI) becomes MédiS SENEGAL in 2017

MédiS SENEGAL employs 170 experimented people and is specialized in manufacturing

and distribution of sterile ampoules, tablets and syrups in Senegal and sub-Saharan

Africa

Our Targets

Widen the range by the Group products-portfolio

Develop specific and essential medicines adapted to the needs of the area

Manufacturing and marketing

of medicines for West Africa

MANUFACTURING UNITS

TUNISIA

Access to the Site

Administration

MédiS I :Steril Form

MédiS II :Steril Form

MédiS III Dry forms

/ NEAPOLIS PHARMA :

Dry Powder for inhalation (DPI)

Social Bloc

Quality Control

Laboratory

Warehouse

NEAPOLIS PHARMA :

Oncology Unit

Injectable

Biotechnology

DPI

Oncology

Solid and liquid forms

MédiSI

MédiSII

MédiSIII

NEAPOLIS

First unit

5 000 m²

7 lines of production for the injectable

Forms

5 000 m²

2 lines of production of high capacity for

injectable Forms

7 000 m²

5 lines: oral solid and mono-dose liquids

automatic lines

Unité d’Oncologie : 3 700 m²

Injectable, oral and a dedicated Quality

Control Laboratory

DPI unit

Quality Control Laboratory

Warehouse

2 000 m²

chemistry , microbiology et

biotechnology

6 000 Pallets

Injectable

Biotechnology

DPI

Oncology

Solid and liquid forms

Biotechnology

Technical team : 23 specialized staff

Partnership and technology transfer with

leaders in the sector

Specially dedicated lines : Injectable Forms,

Lyophilisates, pre-filled Syringes

Dedicated quality control laboratory :

HPLC, Electrophoresis , ELISA,

UV-Spectrophotometry …

MédiS expansion intointernational markets

More than 1500 employees worldwide

More than 125 Millions dollars of Turnover / year, in more than 25 countries

Opening towards new horizons…

Commercial

presence :

SAUDI ARABIA

UAE

OMAN

JORDAN

LEBANON

YEMEN

IRAQ

SYRIA

ALGERIA

LIBYA

MOROCCO

MAURITANIA

FRANCOPHONE AFRICA

…..

TUNISIA

ALGERIA

CZECH. REP

SENEGAL

ProductionSites :

----

EXCHANGES OF EXPERTISE AND KNOW-HOW

MédiS GROUP

PORTFOLIO

INNOVATION IN THE STRATEGIC CHOICES

LYOPHILISATES

PREFILLED SYRINGES

DENTAL CARTRIDGES

ONCOLOGY

BIOTECHNOLOGYDPI

NUMBER OF MAA OF THE

GROUP WORLDWIDE : 1 235

In Tunisia

In Africa

In Midlle East

In Russia 4

280

889

62

THERAPEUTIC AREAS

CERTIFICATIONS AND

MANUFACTURING LICENSE

CERTIFICATIONS AND

MANUFACTURING LICENSE

GMP STANDARDSEuropean

SPECIFIC STANDARDSSaudi Arabia

CERTIFICATIONS AND

MANUFACTURING LICENSE

SPECIFIC STANDARDSGHC

CERTIFICATIONS AND

MANUFACTURING LICENSE

SPECIFIC STANDARDSJordan

CERTIFICATIONS AND

MANUFACTURING LICENSE

SPECIFIC STANDARDSYemen

CERTIFICATIONS AND

MANUFACTURING LICENSE

SPECIFIC STANDARDSSudan

CERTIFICATIONS AND

MANUFACTURING LICENSE

SPECIFIC STANDARDSSenegal GMP

CERTIFICATIONS AND

MANUFACTURING LICENSE

SPECIFIC STANDARDSIvory Coast

CERTIFICATIONS AND

MANUFACTURING LICENSE

RED CROSS

CERTIFICATIONS AND

MANUFACTURING LICENSE

NEAPOLIS

CERTIFICATIONS AND

MANUFACTURING LICENSE

INPHA-MEDIS

CERTIFICATIONS AND

MANUFACTURING LICENSE

Thanks